Fatos interessantes

• Pfizer apresenta novos dados sobre o seu fármaco para a dor neuropática Lyrica® - RCM Pharma
  

  Pfizer apresenta novos dados sobre o seu fármaco para a dor neuropática Lyrica®RCM PharmaA Pfizer apresentou na sexta-feira sete abstracts sobre o seu medicamento para a dor neuropática Lyrica® (pregabalina), na reunião anual da American Pain Society, incluindo uma investigação exploratória utilizando ressonância magnética funcional (fMRI) .

• Def Leppard: novos produtos inspirados no 'Rock of Ages' - Whiplash! RockSite
  

  Def Leppard: novos produtos inspirados no 'Rock of Ages'Whiplash! RockSiteOs roqueiros britânicos se uniram com os designers de 'Cultura Lyrica' para criar uma linha de equipamento de rock elegante.

• Pfizer Exploratory Study Measures Effects Of Lyrica On Brain Activity In ... - The FINANCIAL (press release)
  

  EON: Enhanced Online News (press release)Pfizer Exploratory Study Measures Effects Of Lyrica On Brain Activity In .

• Hot Topics and Readers' Notes - 05-23-12 - ProHealth
  

  Hot Topics and Readers' Notes - 05-23-12ProHealthNote: This study reported that Lyrica reduced average waking time after sleep onset by 19 minutes and average total sleep time by 25.

• Pfizer's Lyrica falls short in two pain studies - Newsday
  

  NewsdayPfizer's Lyrica falls short in two pain studiesNewsdayHealth Newsday New York > News > Health Print Aa Pfizer's Lyrica falls short in two pain studies Published: May 6, 2012 9:17 AM By REUTERS Pfizer Inc's big-selling Lyrica drug failed to help HIV patients and diabetics relieve forms of nerve pain, .